Computer-aided diagnosis can facilitate the early detection and diagnosis of multiple sclerosis (MS) thus enabling earlier interventions and a reduction in long-term MS-related disability. Recent advancements in the field of artificial intelligence (AI) have led to the improvements in the classification, quantification and identification of diagnostic patterns in medical images for a range of diseases, in particular, for MS. Importantly, data generated using AI techniques are analyzed automatically, which compares favourably with labour-intensive and time-consuming manual methods.
Objective:
The aim of this review is to assist MS researchers to understand current and future developments in the AI-based diagnosis and prognosis of MS.
Methods:
We will investigate a variety of AI approaches and various classifiers and compare the current state-of-the-art techniques in relation to lesion segmentation/detection and prognosis of disease. After briefly describing the magnetic resonance imaging (MRI) techniques commonly used, we will describe AI techniques used for the detection of lesions and MS prognosis.
Results:
We then evaluate the clinical maturity of these AI techniques in relation to MS.
Conclusion:
Finally, future research challenges are identified in a bid to encourage further improvements of the methods.
WangJGuBJMastersCL, et al. A systemic view of Alzheimer disease – Insights from amyloid-β metabolism beyond the brain. Nat Rev Neurol2017; 13(10): 612.
3.
GoldenbergMM.Multiple sclerosis review. Pharmacy and Therapeutics2012; 37(3): 175.
RibbonsKLeaRSchofieldPW, et al. Anxiety levels are independently associated with cognitive performance in an Australian multiple sclerosis patient cohort. J Neuropsychiatry Clin Neurosci2017; 29(2): 128–134.
6.
BarileSPiciocchiPBassanoC, et al. Re-defining the role of artificial intelligence (AI) in wiser service systems. In: International conference on applied human factors and ergonomics, Orlando, FL, 21–25 July 2018, pp. 159–170. Cham: Springer.
7.
ZhangLTanJHanD, et al. From machine learning to deep learning: Progress in machine intelligence for rational drug discovery. Drug Discov Today2017; 22(11): 1680–1685.
8.
SaraGSeraFCattaruzzaMS, et al. Meta-analysis of risk factors for cutaneous melanoma: I Common and atypical naevi. Eur J Cancer2005; 41(1): 28–44.
9.
GongEPaulyJMWintermarkM, et al. Deep learning enables reduced gadolinium dose for contrast-enhanced brain. J Magn Reson Imaging2018; 48(2): 330–340.
10.
Sastre-GarrigaJParetoDBattagliniM, et al. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol2020; 16(3): 171–182.
11.
LeeKParkJKimI, et al. Predicting movie success with machine learning techniques: ways to improve accuracy. Inf Syst Front2018; 20(3): 577–588.
12.
AbduljabbarRDiaHLiyanageS, et al. Applications of artificial intelligence in transport: An overview. Sustainability2019; 11(1): 189.
SchoutenKVan Der WeijdeOFrasincarF, et al. Supervised and unsupervised aspect category detection for sentiment analysis with co-occurrence data. IEEE Trans Cybern2017; 48(4): 1263–1275.
16.
AdhikarySDangwalSBhowmikD.Supervised learning with a quantum classifier using multi-level systems. Quantum Inf Process2020; 19(3): 89.
17.
KarimianAJafariS.A new method to segment the multiple sclerosis lesions on brain magnetic resonance images. J Med Signals Sens2015; 5(4): 238–244.
18.
Goldberg-ZimringDAAchironSMironM, et al. Automated detection and characterization of multiple sclerosis lesions in brain MR images. Magn Reson Imag1998; 16(3): 311–318.
19.
SamarasekeraSUdupaJKMikiY, et al. A new computer-assisted method for the quantification of enhancing lesions in multiple sclerosis. J Comput Assist Tomogr1997; 21(1): 145–151.
20.
YooYBroschTTraboulseeA, et al. Deep learning of image features from unlabeled data for multiple sclerosis lesion segmentation. In: International workshop on machine learning in medical imaging, Boston, MA, 14 September 2014, pp. 117–124. Cham: Springer.
21.
BroschTTangLYYooY, et al. Deep 3D convolutional encoder networks with shortcuts for multiscale feature integration applied to multiple sclerosis lesion segmentation. IEEE Trans Med Imaging2016; 35(5): 1229–1239.
22.
GuoDFridrikssonJFillmoreP, et al. Automated lesion detection on MRI scans using combined unsupervised and supervised methods. BMC Med Imag2015; 15(1): 50.
23.
ZhangSNguyenTDZhaoY, et al. Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions. Neuroimage Clin2018; 18: 143–148.
24.
SchmidtPGaserCArsicM, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. NeuroImage2012; 59(4): 3774–3783.
25.
SudreCHCardosoMJBouvyWH, et al. Bayesian model selection for pathological neuroimaging data applied to white matter lesion segmentation. IEEE Trans Med Imag2015; 34(10): 2079–2102.
26.
ValcarcelAMLinnKAVandekarSN, et al. MIMoSA: An automated method for intermodal segmentation analysis of multiple sclerosis brain lesions. J Neuroimag2018; 28(4): 389–398.
27.
ShieeNBazinP-LOzturkA, et al. A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. NeuroImage2010; 49(2): 1524–1535.
28.
JainSSimaDMRibbensA, et al. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage Clin2015; 8: 367–375.
29.
DeshpandeHMaurelPBarillotC.Classification of multiple sclerosis lesions using adaptive dictionary learning. Comput Med Imaging Graph2015; 46(Pt 1): 2–10.
30.
RoySButmanJAReichDS, et al. Multiple sclerosis lesion segmentation from brain MRI via fully convolutional neural networks. arXiv preprint arXiv:1803.09172, 2018.
31.
BirenbaumAGreenspanH.Multi-view longitudinal CNN for multiple sclerosis lesion segmentation. Eng Appl Artif Intell2017; 65: 111–118.
32.
ValverdeSCabezasMRouraE, et al. Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach. NeuroImage2017; 155: 159–168.
33.
HashemiSRSalehiSSMErdogmusD, et al. Tversky as a loss function for highly unbalanced image segmentation using 3D fully convolutional deep networks. arXiv preprint arXiv:1803.11078, 2018.
34.
AndermattSPezoldSCattinPC. Automated segmentation of multiple sclerosis lesions using multi-dimensional gated recurrent units. In: International MICCAI brain lesion workshop, Quebec City, QC, Canada, 14 September 2017, pp. 31–42. Cham: Springer.
35.
ValverdeSSalemMCabezasM, et al. One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks. Neuroimage Clin2019; 21: 101638.
36.
RehanHMSuhuaiLSaadallahR, et al. Automatic & robust segmentation of multiple sclerosis lesions with convolutional neural networks. Comput Mater Continua2020. DOI: 10.32604/cmc.2020.012448
37.
Ion-MărgineanuAKocevarGStamileC, et al. A comparison of machine learning approaches for classifying multiple sclerosis courses using MRSI and brain segmentations. In: International conference on artificial neural networks, Alghero, 11–14 September 2017, pp. 643–651. Cham: Springer.
38.
ZhaoYHealyBCRotsteinD, et al. Exploration of machine learning techniques in predicting multiple sclerosis disease course. PLoS ONE2017; 12(4): e0174866.
39.
WottschelVAlexanderDCKwokPP, et al. Predicting outcome in clinically isolated syndrome using machine learning. Neuroimage Clin2015; 7: 281–287.
40.
YpermanJBeckerTValkenborgD, et al. Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis. BMC Neurol2020; 20(1): 1–15.
41.
PruenzaCSolanoMTDíazJ, et al. Model for prediction of progression in multiple sclerosis. IJIMAI2019; 5(6): 47–53.
